Moving forward-the 2019 ASCCP Risk-Based Management Consensus Guidelines for Abnormal Cervical Cancer Screening Tests and Cancer Precursors and beyond: implications and suggestions for laboratories

MLA

Carol Eisenhut, et al. “Moving Forward-the 2019 ASCCP Risk-Based Management Consensus Guidelines for Abnormal Cervical Cancer Screening Tests and Cancer Precursors and beyond: Implications and Suggestions for Laboratories.” Journal of the American Society of Cytopathology, vol. 9, no. 4, May 2020. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....ac59c0babad1e9bb922a5b1e76b50cca&authtype=sso&custid=ns315887.

APA

Carol Eisenhut, Teresa M. Darragh, Robert Goulart, Diane Davis Davey, Sana Tabbara, Eric C. Huang, Ritu Nayar, Barbara A. Crothers, & David Chhieng. (2020). Moving forward-the 2019 ASCCP Risk-Based Management Consensus Guidelines for Abnormal Cervical Cancer Screening Tests and Cancer Precursors and beyond: implications and suggestions for laboratories. Journal of the American Society of Cytopathology, 9(4).

Chicago

Carol Eisenhut, Teresa M. Darragh, Robert Goulart, Diane Davis Davey, Sana Tabbara, Eric C. Huang, Ritu Nayar, Barbara A. Crothers, and David Chhieng. 2020. “Moving Forward-the 2019 ASCCP Risk-Based Management Consensus Guidelines for Abnormal Cervical Cancer Screening Tests and Cancer Precursors and beyond: Implications and Suggestions for Laboratories.” Journal of the American Society of Cytopathology 9 (4). http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....ac59c0babad1e9bb922a5b1e76b50cca&authtype=sso&custid=ns315887.